partnership
Secarna Pharmaceuticals and Curie.Bio expand existing partnership
March 6, 2026Research and Development Curie.Bio, Secarna Pharmaceuticals, partnership
Secarna Pharmaceuticals has announced the expansion of the existing scientific and strategic collaboration agreement with Curie.Bio. The collaboration, first announced …
Landmark Bio and Mass General Brigham partner to accelerate translational CGT therapies
October 30, 2025Research and Development Landmark Bio, Mass General Brigham, cell and gene therapies, partnership
Landmark Bio and Mass General Brigham in the US have entered a new strategic collaboration designed to accelerate the development …
Boehringer Ingelheim and LEO Pharma partner to develop treatment for generalised pustular psoriasis
July 21, 2025Medical Communications, Mergers and Acquisitions, Research and Development Boehringer Ingelheim, Dermatology, LEO Pharma, Spevigo, generalised pustular psoriasis, partnership, skin disease
Boehringer Ingelheim and LEO Pharma have partnered to commercialise and further develop Spevigo (spesolimab), a treatment for generalised pustular psoriasis …
PM Society and CIM launch new leadership programme for pharma marketers
June 13, 2025Sales and Marketing CIM Fellowship, Chartered Institute of Marketing (CIM), Corporate, Marketing Excellence Industry Group, PM Society Awards, Pharmaceutical Marketing (PM) Society, Pharmacy, partnership
The Pharmaceutical Marketing (PM) Society has partnered with the Chartered Institute of Marketing (CIM) to launch the PMS & CIM …
Chiesi partners with Key2Brain to develop therapies for rare neurodegenerative diseases
June 12, 2025Manufacturing and Production, Mergers and Acquisitions, Research and Development Chiesi Group, Key2Brain, Neurology, Rare Diseases, lysosomal storage disorders, neurodegenerative disease, partnership, ultra-rare disease
Italian biopharma, Chiesi Group, and Key2Brain, a Swedish biotech, have agreed to advance the development of two blood-brain barrier (BBB)-crossing …
BioNTech and Bristol Myers Squibb collaborate on bispecific antibody for solid tumours
June 6, 2025Research and Development BioNTech, Oncology, bispecific antibody treatment, bristol myers squibb, oncology, partnership
BioNTech and Bristol Myers Squibb (BMS) have entered a partnership to collaboratively develop and commercialise BNT327, BioNTech’s bispecific antibody, to …
Cold Chain Technologies acquires Global Cold Chain Solutions
March 26, 2025Dedicated cold-chain delivery, Manufacturing and Production Global Cold Chain Solutions, Pharmacy, business development, cold chain, life sciences, partnership
Cold Chain Technologies (CCT), a global provider for temperature-sensitive packing and digital solutions, has acquired Global Cold Chain Solutions (GCCS), …
Research collaboration announced between Oxford University and GSK
January 27, 2025Research and Development Cancer, Oncology, Oxford University, neoantigens, partnership, research and development
The GSK-Oxford Cancer Immuno-Prevention Programme was announced at the end of January and will focus on researching the prevention of …
Brainomix and Boehringer Ingelheim enter strategic partnership
July 19, 2024Research and Development Boehringer Ingelheim, Brainomix, Pharmacy, fibrosing lung disease, partnership
Brainomix has announced that it has entered into a strategic partnership with Boehringer Ingelheim for a collaborative programme surrounding the …
Allumiqs and Prolytix enter partnership for acceleration of drug discovery and development
March 15, 2024Research and Development Allumiqs, Pharmacy, drug discovery, partnership
Allumiqs and Prolytix have announced that they have entered into a long-term, strategic partnership with the aim of providing collaboratinve …
ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development
December 7, 2023Research and Development NAYA Biosciences, NK cell therapies, ONK Therapeutics, Oncology, partnership
ONK Therapeutics and NAYA Biosciences have announced that they have entered into a research partnership to assess combination therapies consisting …
UCB syncs up with Roche and Genentech in Alzheimer’s drug deal worth a potential $2bn+
July 30, 2020Research and Development, Sales and Marketing Genentech, Roche, UCB, partnership
UCB Pharma is set to partner up with Roche and Genentech in a development and commercialisation deal focused on its …
AstraZeneca partners with Daichii Sankyo in potential $6bn cancer drug deal
July 27, 2020Research and Development, Sales and Marketing AstraZeneca, Daiichi Sankyo, partnership, pharma
AstraZeneca and Daiichi Sankyo have joined forces to drive the development and commercialisation of the latter’s DS-1062, a trophoblast cell-surface …
Takeda partners up with Carmine Therapeutics to develop and market rare disease candidates
July 1, 2020Research and Development Takeda Carmine, partnership, pharma
Takeda has linked up with Carmine Therapeutics in a new partnership to discover, develop and bring to market new non-viral …
AbbVie and Genmab sign drug development and commercialisation deal worth up to $4bn
June 11, 2020Research and Development AbbVie, Genmab, partnership, pharma
AbbVie has joined forces with Genmab to develop and commercialise three of the latter’s early-stage Genmab drug products – epcoritamab …
